v3.22.2.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Common Stock
RSUs
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (in shares)   102,484        
Beginning balance at Jan. 31, 2021 $ 431,412 $ 10   $ 829,238 $ (45) $ (397,791)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares)   5,824        
Issuance of common stock upon exercise of stock options 17,975 $ 1   17,974    
Exercise of common stock warrants (in shares)   18        
Vesting of restricted stock units (in shares)     1,567      
Vesting of early exercised stock options 147     147    
Issuance of common stock in connection with employee stock purchase plan (in shares)   280        
Issuance of common stock in connection with employee stock purchase plan 4,725     4,725    
Common stock issued in connection with acquisitions (in shares)   1,674        
Common stock issued in connection with acquisitions 30,499     30,499    
Stock-based compensation 39,127     39,127    
Other comprehensive loss (2,361)       (2,361)  
Net loss (89,799)         (89,799)
Ending balance (in shares) at Oct. 31, 2021   111,847        
Ending balance at Oct. 31, 2021 431,725 $ 11   921,710 (2,406) (487,590)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (in shares)   110,133        
Beginning balance at Jul. 31, 2021 447,222 $ 11   904,076 (111) (456,754)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares)   1,344        
Issuance of common stock upon exercise of stock options 4,648     4,648    
Vesting of restricted stock units (in shares)     370      
Vesting of early exercised stock options 49     49    
Stock-based compensation 12,937     12,937    
Other comprehensive loss (2,295)       (2,295)  
Net loss (30,836)         (30,836)
Ending balance (in shares) at Oct. 31, 2021   111,847        
Ending balance at Oct. 31, 2021 $ 431,725 $ 11   921,710 (2,406) (487,590)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (in shares)   111,847        
Beginning balance (in shares) 113,800 113,813        
Beginning balance at Jan. 31, 2022 $ 418,969 $ 11   944,447 (4,333) (521,156)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares)   3,236        
Issuance of common stock upon exercise of stock options 11,479 $ 1   11,478    
Vesting of restricted stock units (in shares)     2,369      
Cancellation of common stock held (in shares)     (28)      
Vesting of early exercised stock options 33     33    
Issuance of common stock in connection with employee stock purchase plan (in shares)   454        
Issuance of common stock in connection with employee stock purchase plan 2,831     2,831    
Stock-based compensation 50,269     50,269    
Other comprehensive loss (6,689)       (6,689)  
Net loss $ (96,919)         (96,919)
Ending balance (in shares) at Oct. 31, 2022 119,800 119,844        
Ending balance at Oct. 31, 2022 $ 379,973 $ 12   1,009,058 (11,022) (618,075)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (in shares)   118,333        
Beginning balance at Jul. 31, 2022 388,504 $ 12   989,459 (9,181) (591,786)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares)   655        
Issuance of common stock upon exercise of stock options 1,732     1,732    
Vesting of restricted stock units (in shares)     884      
Cancellation of common stock held (in shares)     (28)      
Stock-based compensation 17,867     17,867    
Other comprehensive loss (1,841)       (1,841)  
Net loss $ (26,289)         (26,289)
Ending balance (in shares) at Oct. 31, 2022 119,800 119,844        
Ending balance at Oct. 31, 2022 $ 379,973 $ 12   $ 1,009,058 $ (11,022) $ (618,075)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (in shares) 119,800 119,844